Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

83 résultats
Page :
triés par

SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery

 Marian Gutowski , Bérénice Framery , Martin Boonstra , Véronique Garambois , François Quenet , et al.
Surgical Oncology, 2017, 26 (2), pp.153-162. ⟨10.1016/j.suronc.2017.03.002⟩
Article dans une revue hal-02371819v1
Image document

The HER3/ERBB3 receptor: the dark side of the ERBB planet

 Christel Larbouret , Nadège Gaborit , Marie-Alix Poul , André Pèlegrin , Thierry Chardès
Médecine/Sciences, 2015, 31 (5), pp.465-468. ⟨10.1051/medsci/20153105002⟩
Article dans une revue hal-02285139v1

Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.

 Ghislaine Behar , Patrick Chames , Isabelle Teulon , Amélie Cornillon , Faisal Alshoukr , et al.
FEBS Journal, 2009, 276 (14), pp.3881-93. ⟨10.1111/j.1742-4658.2009.07101.x⟩
Article dans une revue hal-00420547v1
Image document

The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation

 Christophe Le Clorennec , Yassamine Lazrek , Olivier Dubreuil , Christel Larbouret , Marie-Alix Poul , et al.
Oncotarget, 2016, 7 (24), pp.37013-37029. ⟨10.18632/oncotarget.9455⟩
Article dans une revue hal-02297403v1
Image document

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

 David Azria , Frédéric Bibeau , Nicolas Barbier , Abderrahim Zouhair , Claire Lemanski , et al.
BMC Cancer, 2005, 5, pp.62. ⟨10.1186/1471-2407-5-62⟩
Article dans une revue inserm-00090458v1

Symplekin promotes tumorigenicity by up-regulating claudin-2 expression

 Michael Buchert , Marina Papin , Caroline Bonnans , Charbel Darido , Warren Raye , et al.
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (6), pp.2628-2633. ⟨10.1073/pnas.0903747107⟩
Article dans une revue hal-03108425v1
Image document

Examination of HER3 targeting in cancer using monoclonal antibodies

 Nadège Gaborit , Ali Abdul-Hai , Maicol Mancini , Moshit Lindzen , Sara Lavi , et al.
Proceedings of the National Academy of Sciences of the United States of America, 2015, 112 (3), pp.839-844. ⟨10.1073/pnas.1423645112⟩
Article dans une revue hal-02276327v1

Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6 th antibody industrial symposium, June 25-26, 2018, Montpellier, France

 Pierre Martineau , Herve Watier , André Pèlegrin , Andrei Turtoi
mAbs, 2019, 11 (5), pp.812-825. ⟨10.1080/19420862.2019.1612691⟩
Article dans une revue hal-02448613v1

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

 Nina Radosevic-Robin , Wilhem Leconet , Myriam Chentouf , Stanislas Du Manoir , Clément Chevalier , et al.
Clinical Cancer Research, 2017, 23 (11), pp.2806 - 2816. ⟨10.1158/1078-0432.CCR-16-1316⟩
Article dans une revue hal-01676378v1
Image document

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

 Jérôme Lacombe , Muriel Brengues , Alain Mangé , Céline Bourgier , Sophie Gourgou , et al.
Radiation Oncology, 2019, 14 (1), pp.142. ⟨10.1186/s13014-019-1351-8⟩
Article dans une revue hal-02371868v1
Image document

Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane.

 Salomé Paillas , Laurent Boudou , Bérengère Piron , Nathalie Kersual , Manuel Bardiès , et al.
Nuclear Medicine and Biology, 2013, epub ahead of print. ⟨10.1016/j.nucmedbio.2013.02.001⟩
Article dans une revue inserm-00815724v1
Image document

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial

 Eric Assenat , David Azria , Caroline Mollevi , Rosine Guimbaud , Nicole Tubiana-Mathieu , et al.
Oncotarget, 2015, 6 (14), ⟨10.18632/oncotarget.3473⟩
Article dans une revue hal-02005981v1
Image document

Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures

 Christel Larbouret , Laurent Gros , André Pèlegrin , Thierry Chardès
Cancers, 2021, 13 (18), pp.4620. ⟨10.3390/cancers13184620⟩
Article dans une revue hal-03360265v1

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

 Charlotte Hoogstins , Leonora Boogerd , Babs Sibinga Mulder , J. Sven D. Mieog , Rutger Jan Swijnenburg , et al.
Annals of Surgical Oncology, 2018, 25 (11), pp.3350-3357. ⟨10.1245/s10434-018-6655-7⟩
Article dans une revue hal-02289226v1
Image document

Anti-HER2 vaccines: new prospects for breast cancer therapy.

 Maha Zohra Ladjemi , William Jacot , Thierry Chardès , André Pèlegrin , Isabelle Navarro-Teulon
Cancer Immunology, Immunotherapy, 2010, 59 (9), pp.1295-312. ⟨10.1007/s00262-010-0869-2⟩
Article dans une revue inserm-00491487v1
Image document

[Anti-HER2 vaccines: The HER2 immunotargeting future?]

 Maha-Zohra Ladjemi , William Jacot , André Pèlegrin , Isabelle Navarro-Teulon
Pathologie Biologie, 2009, epub ahead of print. ⟨10.1016/j.patbio.2009.04.002⟩
Article dans une revue inserm-00396298v1
Image document

Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients

 Bérénice Framery , Marian Gutowski , Karen Dumas , Alexandre Evrard , Nathalie Muller , et al.
Toxicology Reports, 2019, 6, pp.409--415. ⟨10.1016/j.toxrep.2019.04.011⟩
Article dans une revue hal-02931825v1
Image document

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models

 Emilia Rabia , Véronique Garambois , Julie Hubert , Marine Bruciamacchie , Nelly Pirot , et al.
mAbs, 2021, 13 (1), pp.1914883. ⟨10.1080/19420862.2021.1914883⟩
Article dans une revue hal-03360283v1
Image document

Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in Cancers

 Catherine Lozza , Isabelle Navarro-Teulon , André Pèlegrin , Jean-Pierre Pouget , Eric Vivès
Frontiers in Oncology, 2013, 3 (2), pp.332. ⟨10.3389/fonc.2013.00247⟩
Article dans une revue hal-03824440v1
Image document

Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples

 Alexandre Ho-Pun-Cheung , Hervé Bazin , Florence Boissière-Michot , Caroline Mollevi , Joëlle Simony-Lafontaine , et al.
British Journal of Cancer, 2020, 122 (3), pp.397-404. ⟨10.1038/s41416-019-0670-8⟩
Article dans une revue hal-03037393v1

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy

 Nidia Alvarez-Rueda , Maha Zohra Ladjemi , Ghislaine Béhar , Stéphanie Corgnac , Martine Pugnière , et al.
Vaccine, 2009, 27 (35), pp.4826-4833
Article dans une revue hal-00414283v1
Image document

Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using (2) (1) (2)Pb.

 Vincent Boudousq , Laure Bobyk , Muriel Busson , Véronique Garambois , Marta Jarlier , et al.
PLoS ONE, 2013, 8 (7), pp.e69613. ⟨10.1371/journal.pone.0069613⟩
Article dans une revue inserm-00853390v1
Image document

Cyclization of peptides through a urea bond: application to the Arg-Gly-Asp tripeptide.

 Julien Schmidt , Véronique Garambois , Luc Rocheblave , Jean Martinez , André Pèlegrin , et al.
ChemBioChem, 2010, 11 (8), pp.1083-92. ⟨10.1002/cbic.201000062⟩
Article dans une revue istex inserm-00482710v1
Image document

Pregnane X-receptor promotes stem cell-mediated colon cancer relapse

 Chris Planque , Fatemeh Rajabi , Fanny Grillet , Pascal Finetti , François Bertucci , et al.
Oncotarget, 2016, 7 (35), pp.56558-56573. ⟨10.18632/oncotarget.10646⟩
Article dans une revue hal-01431926v1
Image document

Biasing HER4 tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking

 Romain Lanotte , Véronique Garambois , Nadège Gaborit , Christel Larbouret , Astrid Musnier , et al.
Cancer Science, 2020, 111 (7), pp.2508-2525. ⟨10.1111/cas.14458⟩
Article dans une revue hal-03036389v1
Image document

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.

 Wilhem Leconet , Christel Larbouret , Thierry Chardès , Gaëlle Thomas , Madeline Neiveyans , et al.
Oncogene, 2014, 33 (47), pp.5405-14. ⟨10.1038/onc.2013.487⟩
Article dans une revue inserm-00916587v1

INTERACTION OF A WATER SOLUBLE FULLERENE DERIVATIVE WITH REACTIVE OXYGEN SPECIES AND MODEL ENZYMATIC SYSTEMS

 Sarah Foley , Anthony Curtis , Andreas Hirsch , Michael Brettreich , André Pèlegrin , et al.
Fullerenes, Nanotubes and Carbon Nanostructures, 2002, 10 (1), pp.49 - 67. ⟨10.1081/FST-120002929⟩
Article dans une revue hal-01726320v1

New RGD tetracyclopeptide for tumor cell targeting

 Julien Schmidt , Jean Martinez , André Pèlegrin , Florine Cavelier , Eric Vivès , et al.
20 th American Peptide Symposium, Jun 2007, Montreal, Canada. pp.133
Communication dans un congrès hal-00353444v1
Image document

Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer

 Emilia Rabia , Véronique Garambois , Christine Dhommée , Christel Larbouret , Laurie Lajoie , et al.
Frontiers in Immunology, 2023, 14, ⟨10.3389/fimmu.2023.1168444⟩
Article dans une revue hal-04102843v2
Image document

Impact of Mouse Model on Pre-Clinical Dosimetry in Targeted Radionuclide Therapy

 Samir Boutaleb , Jean-Pierre Pouget , Cecilia Hindorf , André Pèlegrin , Jacques Barbet , et al.
Proceedings of the IEEE, 2009, 97 (12), pp.2076-2085. ⟨10.1109/JPROC.2009.2026921⟩
Article dans une revue inserm-00452525v1
Page :